U.S. District Judge Ed Kinkeade on Tuesday, reduced the verdict in the second bellwether trial over Johnson & Johnson’s Pinnacle hip implant from $497.6 million to approximately $151 million. The judge was compelled to reduce the verdict under a Texas state law limiting punitive damages according to a specific formula. The verdict included roughly $360…
DetailsA recent article posted in Forbes, informs readers that bringing new products to market can take years and require so much data proving product safety, that years can go by before consumers have the ability to purchase them. To circumvent this the FDA has provided a “fast-track” for companies that promise to continue collecting market evidence of consumer…
DetailsJohnson & Johnson, the manufacturer of Pinnacle hip prosthetics, has asked that pending bellwether trials be put on hold while it appeals the recent $497.6 million verdict awarded in March of this year. J&J’s attorneys filed post-trial motions and have indicated that depending on the outcome of those motions an appeal may be filed in…
DetailsSocial media has become an integral part of the way we communicate with individuals and other businesses. It’s a platform where we can promote ourselves as well as access information on almost anything. However, social media is a double-edged sword. Though it may be fun and useful, it can be incredibly dangerous. There are plenty of…
DetailsThis year marks the 10th anniversary of Showard Law Firm. After 18 years of practice, and a prior ten-year partnership, Sarah Showard and her longtime assistant, Maria De La Rosa, opened the doors of Showard Law Firm in October 2006. Sarah and everyone at Showard Law Firm is proud to serve Southern Arizona as the…
DetailsThe FDA, last week strengthened warnings over four diabetes drugs that may cause life-threatening kidney damage. The four medications are: -Farxiga -Xigduo XR -Invokana, and -Invokamet The new labels will have more information about acute kidney injuries and recommendations about how to minimize risk. The FDA says that they have received 101 reports of acute…
DetailsThe FDA has issued a warning to doctors and patients that a common over the counter anti-diarrhea drug can cause deadly heart rhythms when taken at higher than recommended doses. The drug loperamide is sold over the counter or by prescription and is available in generic, store-brand and brand-name (Immodium A-D) versions. The use of…
DetailsLyrica, a widely prescribed pain medication that is heavily advertised on television may be associated with a higher risk of major birth defects. The journal Neurology reported on the study online on May 18, 2016. The study involved 164 women who took Lyrica during their first trimester of pregnancy. These women were compared to a…
DetailsA recent study published in the online issue of Neurology, the medical journal of the American Academy of Neurology indicates that the multiple Sclerosis drug mitoxantrone may be associated with an increased risk of colorectal cancer. The drug is prescribed for aggressive types of relapsing remitting or progressive MS that don’t respond to other MS…
DetailsThe FDA issued a safety announcement on Thursday regarding commonly prescribed antibiotics such as Cipro and Levaquin. The announcement follows an FDA advisory panel in which 35 people testified about severe fluoroquinolone associated disability resulting from the use of Levaquin, Cipro, and Avelox. The drugs have been sold for more than 20 years and are…
Details